A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
To evaluate and to compare efficacy and safety of a dual regimen with oral modified release tacrolimus FK506E (MR4) / steroids versus a dual regimen with oral tacrolimus FK506 / steroids in patients undergoing primary liver transplantation. It shall be demonstrated that FK506E (MR4) is non-inferior to FK506 with regards to the primary endpoint.
Epistemonikos ID: efb2bdd128b669ac8be58432b964c1bcfad26c6e
First added on: May 04, 2024